Huadong Pharmaceutical
Scope
Date
~
-
Bio & Pharma
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
9 HOURS AGO
-
Corporate governance
Korea’s Hanmi family feud to end as key shareholder mediates
South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder h...
Jul 11, 2024 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma exports Alyglo to US
South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...
Jul 09, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem launches Synovian in China
South Korea's LG Chem Ltd. announced on Wednesday that it launched its homegrown new drug for osteoarthritis Synovian (marketed in China as Hyruan O...
Jul 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Indonesia's IPB to co-research on primate
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it signed a contract with Indonesia's Bogor Agricultural University (Institut P...
Jun 27, 2024 (Gmt+09:00)
-
Corporate governance
Hanmi to fire founder's wife, entering new round of family feud
South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...
May 13, 2024 (Gmt+09:00)
-
Corporate bonds
SK Chemicals' bond oversubscribed with $526 mn demand
SK Chemicals Co., a unit of South Korea’s No. 2 conglomerate SK Group, is set for a successful debt issue as the company’s bond sale has...
Apr 19, 2024 (Gmt+09:00)
-
Bio & Pharma
KKR, Hanmi heirs likely to join hands for controlling stake
The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its ...
Apr 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Medytox to supply $73 mn botulinum toxin to Brazilian firm
South Korea's biopharmaceutical firm Medytox Inc. announced on Tuesday that it signed a contract with Brazilian pharmaceutical company Blau Farmaceu...
Mar 26, 2024 (Gmt+09:00)
-
Logistics
Samsung SDS gets CEIV Pharma certification
South Korea's Samsung SDS Co. said on Wednesday that it has achieved the Center of Excellence for Independent Validators in Pharmaceutical Logistics...
Feb 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds
South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...
Feb 19, 2024 (Gmt+09:00)
-
Batteries
LG Chem sees up to 25% battery sector growth in 2024: report
South Korea’s LG Chem Ltd., the parent of the world’s second-largest electric vehicle battery maker LG Energy Solution Ltd., expects up ...
Jan 18, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics reaches record-breaking annual orders
Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...
Nov 28, 2023 (Gmt+09:00)
-
Chemical Industry
Lotte Fine to invest $99 mn to up green materials sales by 6 times
Lotte Fine Chemical Co., South Korea’s largest ammonia producer, will spend a total of 129 billion won ($99 million) in an aim to become the w...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...
Nov 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang rallies on $1.3 bn deal with Novartis
Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-...
Nov 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis releases Soliris biosimilar in Europe
Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, is rolling out its latest product Epysqli,...
Oct 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biologics partners with Indian company for CDMO
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...
Sep 22, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
SK Chemicals to sell pharmaceutical unit to Glenwood PE
SK Chemicals Co., a South Korean plastic materials producer, is in exclusive talks with Seoul-based Glenwood Private Equity to sell its pharmaceutic...
Sep 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio to sell dementia drug AR1001 in China with partner
South Korea's clinical-stage biotech company AriBio Co. on Wednesday said it signed a memorandum of understanding on strategic cooperation with Chin...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets patent of Nabota as migraine drug in US
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...
Sep 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong applies for approval of Envlo in Saudi Arabia
South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to release Stelara biosimilar in US from March 2025
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it has completed a patent agreement with Johnson & Johnson, the m...
Aug 25, 2023 (Gmt+09:00)
Latest News
- 1 Samsung's financial arms beat No.1 banking group KB in profit
- 2 Korea’s airlines plagued by elevated fuel costs, strong dollar
- 3 LG Uplus offers Korean Air gift cards to 5G subscribers
- 4 SK Bioscience sells stake in US vaccine developer Novavax
- 5 Naver Cloud takes the lead in Korea’s public AI business